SGP is SpyGlass Pharma, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $28.94. Market cap: $968M.
Stock snapshot
| Price | $28.94 |
| Market cap | $968M |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
About SGP
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
Related non-dividend companies
Other non-dividend stocks investors research alongside SGP. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is SGP's current stock price?
SGP (SpyGlass Pharma, Inc.) is currently trading at $28.94.
Does SGP pay a dividend?
SGP (SpyGlass Pharma, Inc.) does not currently pay a regular dividend.
Track SGP in DiviDrip
Add SGP to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search SGP and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.